Green Tea Extract: Why the EGCG Number on the Label Decides Both Whether It Works and Whether It's Safe

Green tea extract (GTE) is one of the most-shelved and one of the most-mislabeled supplements in the U.S. retail market. Every fat-loss stack has it. Every "metabolic support" formula sneaks it in. Every antioxidant line uses it as their headline ingredient. The bottle says "500 mg green tea extract" or "1000 mg green tea leaf" and you assume that number is what the trials studied. It is not, usually. And unlike most supplements where a mislabeled dose just means the product doesn't work, green tea extract mislabeled at the high end has put people in the hospital with acute liver injury.

There is one number on a green tea extract label that determines both whether it works and whether it is safe: the milligrams of EGCG — epigallocatechin gallate — per serving. Everything else on the front of the bottle is decoration. Here is how EGCG dosing works, why the label almost never tells you the number straight, where the working dose sits, where the hepatotoxicity risk sits, and how to read the Supplement Facts panel so the amount in your body matches the amount in the trials.

What green tea extract actually is

Green tea (Camellia sinensis) leaves contain a class of polyphenols called catechins. The four main ones are epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG), and epigallocatechin gallate (EGCG). EGCG is the most abundant catechin in green tea and the one that drives most of the pharmacology the extract is sold for — inhibition of catechol-O-methyltransferase (which slows the breakdown of norepinephrine and drives the small thermogenic effect), inhibition of pancreatic lipase (a fat-absorption angle), inhibition of vascular endothelial growth factor (the anti-angiogenic mechanism the oncology literature explores), and a broad antioxidant profile that acts differently at different doses.

A brewed cup of green tea — a normal serving — contains somewhere in the 50-100 mg range of EGCG, depending on the tea, the water temperature, and the steep time. A typical daily green tea consumption in East Asian populations, where most of the epidemiology comes from, is 3 to 5 cups a day, or roughly 150 to 500 mg of EGCG per day, sipped across the day, always with food or as a food adjunct.

Green tea extract is what you get when you take green tea leaves, run them through a solvent extraction to concentrate the polyphenols, and dry the concentrate. Extraction ratios vary — a 10:1 extract is 10 kg of leaf reduced to 1 kg of powder — and the polyphenol and EGCG content of the final powder depends on the leaf source, the extraction solvent, and the drying method. Manufacturers report the polyphenol and EGCG content as percentages of the final extract weight, and that percentage is what determines whether "500 mg green tea extract" means 45 mg of EGCG (a low-grade unstandardized product) or 400 mg of EGCG (a highly standardized "98% polyphenol, 50% EGCG" grade).

The five labels you will actually see on the shelf

If you take fifteen green tea extract products off the shelf right now, the labels break into five patterns. Only two of them tell you the EGCG dose without math.

Label pattern one: "Green Tea Leaf 500 mg." This is the worst label. It tells you the mass of leaf powder in the capsule — not extract, not concentrated — with no standardization at all. A 500 mg green tea leaf capsule contains something in the 15-25 mg range of EGCG at typical leaf catechin content. It is the equivalent of a fraction of a cup of tea in a capsule. Products at this labeling grade rarely do anything measurable and are usually cheap for the reason that they are cheap. Skip.

Label pattern two: "Green Tea Extract 500 mg." This tells you the mass of the extract with no polyphenol or EGCG percentage. Without the standardization, 500 mg of extract could be anywhere from 45 mg to 300 mg of EGCG depending on the manufacturer's process. The label is technically not lying; it is legally accurate. It is also useless for dose math.

Label pattern three: "Green Tea Extract 500 mg (standardized to 50% polyphenols)." This is a partial disclosure. You know the polyphenol content by mass — 250 mg of polyphenols — but polyphenols include all the catechins plus theaflavins and other compounds; the EGCG fraction of the polyphenols is typically 45 to 65%. So 250 mg of polyphenols contains somewhere in the 110-165 mg of EGCG range. Better than pattern two, still not precise enough.

Label pattern four: "Green Tea Extract 500 mg (standardized to 45% EGCG)." This is the honest label. The math is direct: 500 mg × 45% = 225 mg of EGCG per capsule. You know what you are getting. This is the label pattern the trials use in their published methods, and it is the label pattern that lets you compare your product to a specific trial dose.

Label pattern five: "EGCG 300 mg (from green tea extract)." This is the most honest label of all. The 300 mg on the front is the EGCG content directly, and the extract line explains the source. Products with this label pattern are usually the pharmacy-grade or research-supply catechin products, and they tend to cost more per bottle — because the standardization to a specific EGCG number is the expensive part of the manufacturing process.

The label patterns to avoid are one, two, and three. The label patterns to prefer are four and five. If the bottle you own is a pattern-one or pattern-two label, you cannot know what dose you are taking, and you cannot know whether you are under the ineffective threshold or over the hepatotoxicity threshold. Both matter.

The working EGCG dose

The literature that actually shows measurable effects from green tea extract clusters into three dose bands, each with different intended endpoints.

Low dose (100-200 mg EGCG/day): This is the range of habitual green tea drinking translated into extract form. The cardiovascular and antioxidant literature has some support at this dose, particularly for endothelial function and LDL oxidation resistance. The effect size is small in the trials that show one at all, and this is the dose range most compatible with taking the extract long-term as a daily supplement without a meaningful safety concern.

Moderate dose (200-400 mg EGCG/day): This is the range most of the fat-loss and metabolic trials studied. The catechin literature on 24-hour energy expenditure shows a 3-4% thermogenic bump at these doses when combined with caffeine (roughly 100 mg caffeine), which over a 12-week period produces a modest fat-loss effect in overweight participants. The effect is real but small — usually 1-2 kg over 12 weeks against a matched placebo, when the diet and training conditions are held constant. This dose is where most consumer supplements sit and where the risk-benefit tradeoff is best when the product is taken with food.

Higher dose (500-800 mg EGCG/day): This is where the pharmacology gets stronger and the safety risk gets non-trivial. The oncology literature on chemoprevention runs at these doses; some cognitive and glucose-metabolism trials do too. This is the dose range where the hepatotoxicity signal emerges in the case-report literature — most reported cases of green-tea-extract-associated liver injury involved doses of 500 mg of EGCG or more per day, particularly taken in the fasted state and often in the context of a weight-loss product where the label did not disclose the actual EGCG content.

Above 800 mg EGCG/day: the risk-benefit tradeoff flips. Trials that pushed the dose above 800 mg saw both a small increase in effect and a substantial increase in transaminase elevations. Regulatory bodies in Europe have set a 800 mg/day upper limit for green tea catechins from extracts based on this signal.

The practical working dose for the healthy adult using green tea extract for its metabolic and cardiovascular effects sits in the 200-400 mg of EGCG per day range, taken with food, split across two doses if the total is over 300 mg. That is the dose range that has evidence for effect and does not appear in the hepatotoxicity case-report literature at meaningful frequency.

The hepatotoxicity story

This is the reason the EGCG number matters more than in almost any other supplement category. Green tea extract has been associated with case reports of drug-induced liver injury (DILI) since roughly 2007, and the reports have accumulated to the point where multiple regulatory bodies have issued warnings and set upper limits.

The clinical picture in the reports is remarkably consistent. A previously healthy adult, usually between 20 and 60 years old, starts taking a green tea extract product — often as part of a weight-loss stack — and after 1 to 3 months of daily use presents with fatigue, nausea, upper abdominal discomfort, and dark urine. Labs show markedly elevated ALT and AST, often 10 to 40 times the upper limit of normal, with a hepatocellular injury pattern. Most cases resolve within weeks of discontinuing the product. A small number progress to acute liver failure requiring transplant, and a handful have been fatal.

The mechanism appears to be an idiosyncratic hepatotoxic response mediated by EGCG, potentially dose-dependent, with an interaction with fasted-state consumption. Studies in animals and controlled clinical exposure work suggest that EGCG plasma concentrations are substantially higher when the extract is taken in the fasted state than when taken with a meal — the difference can be 3-fold or more — and the fasted-state peak concentrations are the ones that appear to drive the hepatotoxicity signal. Taking the same dose with a meal appears to reduce both peak plasma EGCG and the reported risk.

The 2018 EFSA (European Food Safety Authority) review concluded that daily EGCG doses of 800 mg or more from green tea extract carry a safety concern, that some case reports exist even at 500 mg or lower in the fasted state, and that the risk is higher when the product is taken between meals or on an empty stomach. The UK's Committee on Toxicity reached similar conclusions. The U.S. FDA has not set a formal upper limit but has issued warnings about specific products.

The rules for reducing the risk are practical and short: take the extract with food, split the daily dose if you are running over 300 mg EGCG per day, do not stack multiple green-tea-containing products (weight-loss formulas often quietly contain green tea extract alongside a separately labeled "green tea extract" product, doubling the EGCG dose without the consumer knowing), and stop the product immediately if you notice fatigue, right-upper-quadrant discomfort, dark urine, or jaundice.

Who should not take green tea extract at all

Three populations should not use green tea extract in supplement form.

Anyone with existing liver disease — chronic hepatitis, fatty liver disease, alcoholic liver disease, or a history of drug-induced hepatitis — should skip GTE entirely. The compromised liver has a narrower safety margin against any hepatotoxic exposure, and the case-report literature specifically flags the population with baseline liver issues as higher risk.

Anyone on hepatotoxic medications — statins, methotrexate, acetaminophen at chronic doses, certain antibiotics, some antifungals — adds cumulative hepatic stress that raises the risk of a GTE-associated liver event. If you are on any medication with a hepatic clearance and known transaminase-elevation profile, discuss GTE with your prescriber before adding it.

Anyone pregnant or breastfeeding. The catechin exposure literature in pregnancy is thin, and the modest fat-loss effect that is the main reason for adult use of the extract is not a reason to introduce an uncertain hepatic exposure to the fetus or the nursing infant.

What the label check looks like in practice

Take the green tea extract product you own and look at the Supplement Facts panel. If the panel does not list an EGCG number in milligrams, put the product back and buy one that does. If the panel lists a polyphenol percentage but no EGCG number, the EGCG content is roughly 45-65% of the polyphenol mass — do the math, and if you are unsure, prefer a product with the EGCG standardization stated directly.

Confirm the EGCG dose per serving. If it is over 300 mg per capsule, decide whether that is the dose you actually want. If you are running the product at more than one serving per day, add the EGCG doses and check the total against the 200-400 mg working range.

Check whether the product is a stand-alone GTE or part of a stack (fat burner, metabolism support, etc.). If it is in a stack, other ingredients may also contain green tea extract or caffeine that compounds the EGCG or the stimulant load; read the entire ingredient list, not just the front-of-panel headline.

Take the product with food. Not before a fasted training session, not with morning coffee only, not as a between-meal supplement — with a real meal. This is the single most protective habit against the hepatotoxicity signal.

The one-paragraph summary

The mass of green tea extract on the front of the bottle is not the dose. The dose is the milligrams of EGCG inside the extract, which depends on the standardization, which is on the Supplement Facts panel or should be. The working range for measurable metabolic and cardiovascular effects is 200-400 mg of EGCG per day taken with food. Above 500 mg per day in the fasted state is where the hepatotoxicity case reports cluster. Products that do not disclose the EGCG number cannot be dose-checked and should be replaced with products that do. Read the panel. Take with food. Stop the product at any sign of hepatic symptoms. The label is doing more work here than in almost any other supplement category — read it carefully.